health
Takeda and Dr. Reddy''s Laboratories Enter Into Exclusive Collaboration to Promote and Distribute QDENGA® in India''s Pediatric and Adult Private Market
Collaboration focuses on disease awareness, promotion and distribution of Takeda’s dengue vaccine, across India’s private market for pediatric and adult vaccination, ahead of its anticipated availability in the first half of 2027. Collaboration combines Takeda’s global dengue and vaccine expertise with Dr. Reddy’s extensive healthcare network and commercial reach across India. Hyderabad, Telangana, Mumbai, Maharashtra, India --- Business Wire India Takeda Pharmaceutical Company Limited, through
Collaboration focuses on disease awareness, promotion and distribution of Takeda’s dengue vaccine, across India’s private market for pediatric and adult vaccination, ahead of its anticipated availability in the first half of 2027. Collaboration combi... [16592 chars]
Read Full ArticleShare this story
Up next
Related Stories
What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise
The Economic Times
Study Links Oral Menopausal Hormone Therapy to Thrombotic Risk
Drug Topics
Smartphone retinal imaging could expand global eye care screening
News-Medical
Why does endometriosis only cause major pain for some?
Futurity
Are You Always Up Past Midnight? Study Reveals How Sleeping Late May Affect Your Body’s Cancer Defences
News18